NCT02485093View on ClinicalTrials.gov

To Pace or Not to Pace in Sinus Node Disease

NACompletedINTERVENTIONAL

Enrollment

215

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

July 31, 2013

Study Completion Date

October 31, 2014

Conditions

Sinus Node Disease

Interventions

DEVICE

Septal ventricular pacing

Ventricular pacing must be at least 90%, from the septum and with optimized AV delay

DEVICE

VIP

Ventricular pacing must be less than 10%.

Trial Locations (1)

35000

CHU Pontchaillou - CCP, Rennes

Sponsors

Lead Sponsor

Abbott Medical Devices

All Listed Sponsors

lead

Abbott Medical Devices

INDUSTRY